Stockreport

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024

Bioventus Inc. - Class A  (BVS) 
PDF DURHAM, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today [Read more]